跳至主要内容
临床试验/NCT02778152
NCT02778152已完成不适用

Pilonidal Disease Laser Depilation Pilot Study

Peter Minneci2 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2016年2月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
13
试验地点
2
主要终点
Tolerability of Laser Treatment

研究概览

简要总结

Pilot study to assess tolerability and safety of laser hair depilation in adolescents and young adults with pilonidal disease.

详细描述

This is a pilot study to measure safety and tolerance of laser hair depilation in adolescents and young adults with pilonidal disease as a potential treatment to intervene on future recurrence.

Up to a total of 10 patients will be enrolled.

Each patient will be involved in the study for one year. Patients will be brought into Surgery clinic for 1 laser treatment every 4-6 weeks to obtain a total of 5 treatments. Follow up will occur monthly from the time of initial treatment through 1 year after the last treatment as we evaluate for tolerance and efficacy.

Inclusion Criteria

  • English and non-English speaking patients
  • All Fitzpatrick skin types
  • Age : 12-20 years
  • Diagnosis of pilonidal disease

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • English and non-English speaking patients
  • All Fitzpatrick skin types
  • Age : 12-20 years
  • Diagnosis of pilonidal disease

排除标准

  • History of photosensitivity
  • Actively inflamed pilonidal sinus

研究组 & 干预措施

Laser depilation

Experimental

Laser depilation to the natal cleft (pilonidal region) monthly for 5 treatments with either an 810nm of Nd:YAG laser dependent on Fitzpatrick skin type and tolerability.

干预措施: Laser depilation (Device)

结局指标

主要结局

Tolerability of Laser Treatment

时间窗: five months

Median of pain scores immediately post-laser treatment after each of the 5 treatments. Pain was assessed on a scale of 1 to 10, 10 being the greatest amount of pain.

次要结局

  • Number of Participants Experiencing Second Degree Burns Post-Treatment(five months)

研究者

发起方
Peter Minneci
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Peter Minneci

Principal Investigator

Nationwide Children's Hospital

研究点 (2)

Loading locations...

相似试验